Added to YB: 2024-12-20
Pitch date: 2024-12-20
GUD:CN [bullish]
Knight Therapeutics Inc.
+92.05%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Knight Therapeutics Inc. focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.
Market Cap
CAD 967.1M
Pitch Price
CAD 5.16
Price Target
N/A
Dividend
N/A
EV/EBITDA
12.08
P/E
174.30
EV/Sales
1.75
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Knight Therapeutics, Inc. GUD:CN
A summary for this pitch has not been created yet.
Read full article (0 min)